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Embryonic stem cell-derived cardiomyocytes (ESC-CMs) hold great interest in many ﬁelds
of  research including clinical applications such as stem cell and gene therapy for car-
diac repair or regeneration. ESC-CMs are also used as a platform tool for pharmacological
tests or for investigations of cardiac remodeling. ESC-CMs have many  different aspects of
morphology, electrophysiology, calcium handling, and bioenergetics compared with adult
cardiomyocytes. They are immature in morphology, similar to sinus nodal-like in the elec-
trophysiology, higher contribution of trans-sarcolemmal Ca2+ inﬂux to Ca2+ handling, and
higher dependence on anaerobic glycolysis. Here, I review a detailed electrophysiology and
Ca2+ handling features of ESC-CMs during differentiation into adult cardiomyocytes to gainardiomyocytes
lectrophysiology
mbryonic stem cell
on channels
insights into how all the developmental changes are related to each other to display cardinal
features of developing cardiomyocytes.
© 2016 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND license
fewer mitochondria and are predominantly glycolytic..  Introduction
mbryonic stem cell-derived cardiomyocytes (ESC-CMs) are
reatly promising for stem cell therapy against cardiovascu-
ar diseases such as myocardial infarction and potentially
ife-threatening arrhythmias because of their ability to dif-
erentiate into sinus–nodal, atrial, or ventricular-type of
1,2ardiomyocytes. ESC-CMs also have a potential to be a
ovel pharmacological tool in, for example, high-throughput
creening tests of newly developed drug for cardiotoxicity.3 In
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addition, ESC-CMs could be a powerful new model system to
study mechanisms of inherited cardiomyopathies.4
ESC-CMs are immature in both morphological and
functional aspects. They have underdeveloped contractile
machinery and lack transverse-tubular (T-tubular) system.5,6
They display diastolic potentials similar to those of adult
sinus–nodal cells and slower upstroke velocity.1,2 They have
5 7l Signaling, Department of physiology and Biophysics, College of
, 75, Bokji-ro, Busanjin-Gu, Busan, 614-735, Korea.
Ca2+ handling is also signiﬁcantly different from that
of their adult counterpart displaying slower kinetics and
smaller amplitude.8 This review will primarily focus on the
vier. This is an open access article under the CC BY-NC-ND license
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Table 1 – Model parameter values in mathematical
model*
Model
parameters
Nodal type
(AP)
Atrial type
(AP)
Ventricular
type (AP)
ECaL, mV 47 47 47
gCaL, nS 11.0140 12.5874 12.5874
k1 0.9 1.1 1.8
k2 1.0 1.3 2.2
gHCN,Na, nS 0.0529 0.0529 0.0529
gHCN,K, nS 0.0851 0.0851 0.0851
gto,UF, nS 0.3346 1.3382 0.6691
gto,F, nS 0.1338 0.5352 0.2676
gto,S, nS 0.2091 0.8364 0.4182
gKs, nS 0.0411 0.2057 0.4114
gb,Ca, nS 0 0 0
gb,Na, nS 0.170 0.122 0.122
gb,K, nS 0.035 0.025 0.025
gCaT, nS 0 0 0
gKl, nS 0 0.6075 2.2275
gKr, nS 1.5319 0.6383 0.6383
gNa,1.5, nS 0.0059 0.0237 0.0296
gNa,1.1, nS 0.0059 0.0237 0.0296
gst, nS 0 0 0
gsus, nS 0 0 0
∗ See glossary of Kharche et al’s9 model for detailed explanation of
each channel.
Note. Adapted from “Dual modulation of the mitochondrial per-
meability transition pore and redox signaling synergistically
promotes cardiomyocyte differentiation from pluripotent stem
cells,” by S.W. Cho, J.S. Park, H.J. Heo, S.W. Park, S. Song, I. Kim et al.,
2014, J Am Heart Assoc, 3, e000693. Copyright 2014 The Authors.
Fig. 1 – Representative action potential (AP) morphologies
from patch clamp recordings and mathematical modelling.
(A) Nodal type, (B) atrial type, and (C) ventricular type APs
recorded from different embryonic stem cell-derived
cardiomyocytes in a current–clamp mode. Each AP trace in
the middle panel corresponds to an expanded trace of
single AP denoted with an asterisk in the left panel. Each
AP trace in the right panel corresponds to a simulated AP
trace. Dotted lines indicate zero voltage level. (D) Percentile
distribution of three different types of APs in embryonic
stem cell-derived cardiomyocytes. See Table 1 for model
parameters used in the mathematical model.
Note. Fig. 1D is from “Dual modulation of the mitochondrial
permeability transition pore and redox signaling
synergistically promotes cardiomyocyte differentiation
from pluripotent stem cells,” by S.W. Cho, J.S. Park, H.J.
Heo, S.W. Park, S. Song, I. Kim et al., 2014, J Am Heart Assoc,
3, e000693. Copyright 2014 The Authors. Reprinted with
differentiation.10 T-tubule formation was not observed at theReprinted with permission.
AP; action potential.
electrophysiological properties and Ca2+ handling features of
ESC-CMs during differentiation into adult cardiomyocytes.
2.  Electrophysiological  properties  of
ESC-CMs
Early studies on the differentiation of pluripotent mouse
embryonic stem cells (ESCs) into adult cardiomyocytes
revealed that the rhythmic action potentials (APs) of early
differentiated cardiomyocytes are very similar to those of
sinus–node cells.1,2 Terminally differentiated cardiomyocytes
generated APs similar to those of adult sinus–nodal, atrial,
and ventricular myocytes, suggesting that there should be
developmental changes in cardiac ion channels and calcium
handling properties along with differentiation into adult car-
diomyocytes. Representative traces of nodal-like, atrial-like,
and ventricular-like APs from patch–clamp recording and
mathematical modelling are demonstrated in Fig. 1. The
mathematical model was based on the Kharche’s model9 and
modiﬁed parameters are summarized in Table 1. In the fol-
lowing, functional changes in electrophysiological properties
during differentiation are described in detail.
2.1.  CapacitanceIn one early study on mouse ESC-CMs, membrane capacitance
was found to steadily increase from 24.5 pF to 50.0 pF duringpermission.
differentiation.10 As the speciﬁc membrane capacitance was
calculated to be 0.85–0.86 F/cm2, it was concluded that
the T-tubular system apparently was not developed duringultrastructural level in human pluripotent stem cell-derived
cardiomyocytes, when electron microscopy or membrane
staining by Di-8-ANNEPPS were used.6
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.2.  L-type  Ca2+ current
-type Ca2+ current (ICaL) is the most prominent inward cur-
ent at the early stage of differentiation in mouse ESC-CMs
nd is found throughout the entire differentiation period.10
he maximum current density (pA/pF) occurred near 0 mV
nd were apparently 13 pA/pF at early stage and 25 pA/pF
t terminally differentiated stage, respectively. ICaL is thought
o synchronize multiple local Ca2+ releases (LCRs) to induce
lobal Ca2+ release.11
The mRNA  of CACNA1C,  a gene encoding one subtype of L-
ype Ca2+ channel, was detected in undifferentiated human
SCs and at all stages of differentiation by using reverse
ranscription–polymerase chain reaction (RT-PCR) analysis.12
CaL was recorded in both human ESCs and ESC-CMs at all
tages of differentiation. Maximum current densities were
.9 pA/pF in human ESCs and 5.8 pA/pF in human ESC-CMs,
espectively.12
As for the pharmacology, there is a report13 that human
SC-CMs have an altered pharmacology for activators of ICaL
hile the pharmacology for antagonist is preserved.
.3.  T-type  Ca2+ current
n inward current permeable for Ca2+ and Ba2+ with lower
hreshold for activation than that of ICaL was detected in
n early study on differentiation of pluripotent ESCs of the
ouse.10 As it was insensitive to 1,4-dihydropyridines but
as almost completely blocked by 50 M Ni2+, the T-type Ca2+
hannel was suggested to be the candidate channel to allow
he inward current.
.4.  Voltage-gated  Na+ current
he density of voltage-gated Na+ current (INa) in mouse ESC-
Ms  was 95 pA/pF at the early differentiation stage and
ncreased to above 300 pA/pF at the terminal differentiation
tage.10 INa was predominantly observed in atrial-like and
entricular-like cells but to a lesser degree in sinus-nodal-
ike cells. The density of INa in human ESC-CMs was 244
A/pF at mid-stage (20–35 days postplating).14 As the spon-
aneous electrical activity from cell clusters was completely
bolished by perfusion of tetrodotoxin, a speciﬁc blocker of INa,
t was suggested that the INa is crucial for initiation of spon-
aneous excitation in cell clusters at mid-stage development.
nterestingly, an AP clamp using the morphology of APs from
uman ESC-CMs elicited a larger early and late INa than that
sing the morphology of APs from either the canine epicardial
r endocardial ventricular myocytes in some voltage-gated
a+ channel (NaV1.5) variants.15 The proposed mechanism
as that the AP from human ESC-CMs displays a relatively
lower upstroke velocity than those from canine ventricular
yocytes, which induces increased open probability and driv-
ng force of INa.15
.5.  Voltage-gated  K+ current transient outward current (Ito) was found from the very
arly stage of differentiation in mouse ESC-CMs.10 The den-
ity of Ito was 14.9 pA/pF at the early differentiation stage and5
41.5 pA/pF at the terminal differentiation stage, respectively.
The 4-aminopyridine sensitive transient outward current (Ito)
was also observed in the other early stage murine cardiomy-
ocytes where the current density was 10.3 pA/pF.16 In human
ESC-CMs, expression of two isoforms, Kv1.4 and Kv4.3, was
detected by RT-PCR.12 The two isoforms were not detected
in undifferentiated human ESC. A 4-aminopyridine sensitive
transient outward current was also recorded in the presence
of intracellular EGTA, a chelator of Ca2+, indicating that it is
the Ca2+-independent transient outward K+ current (Ito1). Its
peak density increased during development from 4.2 pA/pF to
7.7 pA/pF.
The delayed rectiﬁer K+ current was not detectable at the
early stage of differentiation but was seen only at the inter-
mediate and terminal differentiation stages.10 The density of
delayed rectiﬁer K+ current was 3.5 pA/pF at the intermediate
differentiation stage and 9.4 pA/pF at the terminal differenti-
ation stage.
Gryshchenko et al16 identiﬁed two components of rapidly
activating, outwardly rectifying current in early and late stage
cardiomyocytes, which were characterized by slow (IKsus) or no
inactivation (Ires), respectively, during depolarizing test pulses.
Ires was 4-aminopyridine resistant and was observed in 75%
of early stage cardiomyocytes. The maximum current density
was increased from 3.6 pA/pF to 8 pA/pF during differentiation
into late stage cardiomyocytes. Meanwhile, IKsus was observed
in only 25% of early stage cardiomyocytes and its maximum
density was increased from 3.5 pA/pF to 8.3 pA/pF during dif-
ferentiation into late stage cardiomyocytes.
AP durations from beating embryoid bodies cultured
for 40–95 days were signiﬁcantly prolonged by addition of
E4031, a speciﬁc blocker of rapidly activating delayed recti-
ﬁer K+ current (IKr), indicating the ESC-CMs express HERG
channels.17 Even early after-depolarizations appeared after
treatment with E4031. In both undifferentiated human ESCs
and ESC-CMs, the mRNA  of HERG was detected by using RT-
PCR analysis.12 E4031-sensitive outward currents were also
recorded upon depolarizing test pulses from a holding poten-
tial of –40 mV, indicating both undifferentiated human ESCs
and ESC-CMs functionally express HERG channels.
An E4031-resistant but chromanol 293B-sensitive K+ cur-
rent was observed in human ESC-CMs.18 Current-voltage rela-
tionship, activation kinetics, and pharmacological response
all demonstrated that it is the slowly activating delayed rec-
tiﬁer K+ current (IKs). The maximum current density was
apparently 0.7 pA/pF as measured at the end of 2 second depo-
larization test pulse to 40 mV.
2.6.  Inward  rectiﬁer  K+ current
Inward rectiﬁer K+ current (IK1) was observed predominantly
in atrial-like and ventricular-like cells at the terminal differen-
tiation stage.10 The maximum density of IK1 in ventricular-like
cells was slightly increased from 4.9 pA/pF to 5.4 pA/pF during
differentiation into terminal stage. In a study of transgenic
mouse ESCs expressing enhanced green ﬂuorescent protein
(EGFP), both the early sinus–nodal- and atrial-like cardiomy-
ocytes expressed IK1 but the percentage of IK1 expressing
sinus-nodal-like cardiomyocytes was very small compared
with that of IK1 expressing atrial-like cardiomyocytes.19 The
6  
maximum density was also lower in sinus-nodal-like car-
diomyocytes (1.6 pA/pF vs. 3.6 pA/pF). The mRNA  of Kir2.1,
a molecular identity of IK1, was detected in both undifferenti-
ated human ESCs and ESC-CMs by using RT-PCR analysis.12
Ba2+-sensitive background K+ currents were recorded at all
stages of differentiation indicating that human ESC-CMs func-
tionally express IK1.
2.7.  ATP-dependent  K+ current
Some cardiomyocytes in early differentiation were found to
display a bursting behavior of APs, characterized by alter-
nating periods of burst ﬁring and silence.20 The positive
chronotropy by glibencamide, a blocker of ATP-dependent K+
current (IK,ATP) and negative chronotropy by dinitrophenol,
a known activator of IK,ATP, suggest that the ATP-dependent
K+ channels are present and play a role in bursting behavior
of early stage cardiomyocytes. Perforated patch-clamp recor-
dings in the voltage-clamp mode were conducted to isolate
IK,ATP, and the maximum current densities were 45.1 pA/pF in
early stage cells and 90.9 pA/pF in late stage cells, respectively.
The IK,ATP was suggested to mirror the metabolic oscillations
and serve as a cardioprotective role under conditions of low
O2 saturation in the embryo.
2.8.  Acetylcholine-dependent  K+ current
As the carbachol activated inwardly rectifying K+ currents
at the terminal differentiation stage, which was almost
completely blocked by atropine, the presence of acetylcholine-
dependent K+ current was suggested.10 In a study of
transgenic mouse ESC-CMs expressing EGFP, ﬁve out of nine
sinus-nodal-like cardiomyocytes completely stopped sponta-
neous electrical activity in response to carbachol indicating
that acetylcholine-dependent K+ current exists.19 Meanwhile,
only one out of 10 atrial-like cardiomyocytes completely
stopped spontaneous electrical activity by addition of carba-
chol.
2.9.  Hyperpolarization-activated  nonselective  cation
current
Hyperpolarization-activated nonselective cation current (If)
was ﬁrst observed at the intermediate differentiation stage
of mouse ESC-CMs.10 Peak amplitudes of If were between 50
pA and 500 pA at the intermediate differentiation stage and
ranged between 500 pA and 2000 pA at the terminal differ-
entiation stage. Abi-Gerges et al21 found that the percentage
of cardiomyocytes expressing If slightly decreased from 65%
to 45% throughout differentiation. Meanwhile, peak If den-
sities increased from 11.4 pA/pF to 15.5 pA/pF throughout
differentiation. They also demonstrated that the activation
of If during early and late stages of differentiation is not
mediated by direct cAMP binding but by phosphorylation via
protein kinase A. The automaticity seen in atrial-like and
ventricular-like cardiomyocytes during differentiation is in
part due to their relatively high densities of If compared
with those of adult atrial and ventricular cardiomyocytes.
In the study of transgenic mouse ESC-CMs expressing EGFP,
both the early sinus–nodal-like and atrial-like cardiomyocytesIntegr Med Res ( 2 0 1 6 ) 3–10
expressed If and peak densities were about 11 pA/pF and
8 pA/pF, respectively.19 The expression of HCN, a molecu-
lar identity of If, were detected in mouse ESC-CMs and were
signiﬁcantly decreased at Day 23.5 of cell culture compared
with that at Day 9.5.22 Functional expression of If was also
observed in human ESC-CMs.12,14 The mRNA  level for HCN1
isoform, which has the fastest activation kinetics among four
isoforms,23 was not detected in adult heart but was detected
in undifferentiated human ESCs.12 The expression of HCN1
was then signiﬁcantly reduced during differentiation and mat-
uration. By contrast, the mRNA  level for HCN2 isoform with
slower kinetics was persistent throughout the differentiation
process.
2.10.  Ca2+ activated  K+ current
In a study on the pacemaking mechanism of human ESC-
CMs,24 a previously unrecognized Ca2+-activated K+ channel
(KCa3.1, SK4, or IKCa channel) was identiﬁed by using the
patch–clamp technique, real-time PCR, western blotting, and
immunocytochemistry. Pharmacological inhibition of IKCa by
using clotrimazole or 1-[(2-chlorophenyl)diphenylmethyl]-1H-
pyrazole resulted in the depolarization of maximum diastolic
potential and slowing of AP beating rate. It was suggested that
IKCa contributes to shaping of diastolic potential and pace-
maker activity via ﬁne tuning the balance between If and
Na+/Ca2+ exchanger current (INCX).
2.11.  Background  current
Background currents with a linear current–voltage relation-
ship and an apparent reversal potential near 0 mV  were
observed.10 The canonical transient receptor potential isoform
3 (TRPC3) channel, one possible molecular identity of the back-
ground inward current,25 was recently identiﬁed in mouse
ESC-CMs based on immunocytochemistry and patch clamp
recordings.26 Immunocytochemistry revealed that TRPC3 is
located at the T-tubules. A Pyr3-sensitive TRPC3 current was
recorded by whole-cell patch clamp technique. The block of
TRPC3 decreased frequency and amplitude of spontaneous
Ca2+ transients. The most prominent change in spontaneous
AP by Pyr3 was seen in Phase 4 diastolic depolarization which
was signiﬁcantly delayed. As TRPC3 permeates both Ca2+ and
Na+, activation of TRPC3 current is considered to depolarize
the membrane.27 In addition, Ca2+ inﬂux through TRPC3 could
induce LCRs, which subsequently activates the forward mode
of Na+/Ca2+ exchanger (NCX).28
2.12.  INCX
RT-PCR analyses of transcripts were conducted on mouse
ESC-CMs and NCX1 was clearly detectable from preplating
stage.29 The role of NCX was evaluated by using Na+ free solu-
tion, which inhibits NCX resulting in a decreased removal
of Ca2+ from cytosol. In early stage mouse ESC-CMs, basal
level of [Ca2+]i was found to be regulated by NCX, whereas
spontaneous Ca2+ transients were not. In late stage ESC-CMs,
both basal level of [Ca2+]i and amplitude of Ca2+ transi-
ents were affected by NCX. In human ESC-CMs, NCX was
expressed at a higher level than the adult counterpart. The
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i2+-sensitive inward current was recorded in ventricular-like
uman ESC-CMs.30 INCX density was 3.6 pA/pF at 60 mV  in 40-
ay ventricular-like ESC-CMs and increased to 7.9 pA/pF in
0-day. NCX was suggested to translate a sporadic generation
f LCRs into the diastolic depolarization, which in turn acti-
ates L-type Ca2+ currents to generate APs in late-stage mouse
SC-CMs.11
.  Calcium  handling
.1.  [Ca2+]i oscillation  drives  spontaneous  contraction
n early  stage  ESC-CMs
ased on the ﬁnding that the early stage ESC-CMs continue
eating in high extracellular K+ solution, not transmem-
rane ion currents but [Ca2+]i oscillations were suggested as
he mechanism to drive spontaneous contractions of car-
iomyocytes in the early stage of differentiation into adult
ardiomyocytes.31 Interestingly, many  small ﬂuctuations of
embrane potential were superimposed with fewer number
f APs in the early stage cardiomyocytes. 50 nM nisoldip-
ne, a blocker of ICaL, halted APs but not the membrane
otential ﬂuctuations and accompanying spontaneous con-
ractions. The small ﬂuctuations of membrane potential were
ompletely blocked by the addition of thapsigargin, a sar-
oplasmic Ca2+-ATPase inhibitor. Therefore, it was concluded
hat the [Ca2+]i oscillations primarily drive small ﬂuctuations
f membrane potential and that if the ﬂuctuations are big
nough to activate L-type Ca2+ channels, the APs are gener-
ted. Recently, NCX was suggested to translate spontaneous
a2+ oscillations into ﬂuctuations of membrane potential.32
CX was also suggested to translate spontaneous Ca2+ oscilla-
ions into spontaneous inward currents in some voltage clamp
onditions.33 In addition, the [Ca2+]i oscillations in early stage
mbryonic stem cell-derived cardiomyocytes are thought to be
rucial for structural maturation of the cardiomyocytes.34 The
ppearance of spontaneous contractions under high extracel-
ular K+ solution was not observed in terminally differentiated
ardiomyocytes indicating that calcium handling properties
hange with maturation (Fig. 2). In the following, Ca2+ hand-
ing in mouse and human ESC-CMs are described in more
etail.
.2.  Ca2+ handling  in  mouse  ESC-CMs
a2+ sparks, which represent Ca2+ release from the open-
ng of clustered ryanodine receptor channels (RyRs) within
estricted sarcoplasmic reticulum (SR) junctional regions,35
ere not observed in very early developmental stage.36 By con-
rast, global [Ca2+]i ﬂuctuations occurred from the very early
evelopmental stage. Both the Ca2+ sparks and global [Ca2+]i
uctuations were markedly increased in amplitude and fre-
uency during differentiation into late stage cardiomyocytes.
erfusion of either 10 mM caffeine or high extracellular K+
140 mM)  solution to the cardiomyocytes in very early develop-
ental stage resulted in Ca2+ transients indicating that RyRs
nd L-type Ca2+ channels are present and work from the begin-
ing of differentiation. The presence of RyRs in early stage
ardiomyocytes was further conﬁrmed by the ﬁnding that the7
heart rate was markedly depressed in mouse ESC-CMs with
a functional knockout of the RyR2.37,38 The absence of Ca2+
spark in spite of functional RyRs and L-type Ca2+ channels in
the very early developmental stage indicates that they are not
yet in close apposition in the very early stage of differentiation.
Indeed, it was found that there is no colocalization of L-type
Ca2+ channels and RyRs in mouse and human ESC-CMs.39
Although Ca2+ sparks were not observed in RyR2
knockout cells, spontaneous Ca2+ transients were still
observable but with signiﬁcantly slower kinetics.37 The
residual source of Ca2+ increase in RyR2 KO cells is
possibly reverse mode NCX, L-type Ca2+ channels, or
inositol-1,4,5-trisphosphate receptor (IP3R) channels. Indeed,
2-aminoethoxydipheylborate, an inhibitor of store-operated
channels or inositol-1,4,5-trisphosphate (IP3)-induced Ca2+
release,40 signiﬁcantly reduced amplitude of Ca2+ transients.
The inhibitory effect of 2-aminoethoxydipheylborate was sig-
niﬁcantly attenuated at late stage of differentiation indicating
the contribution of IP3Rs to total SR Ca2+ release is downregu-
lated during differentiation.37,41 Furthermore, there is strong
evidence that IP3R and NCX are spatially coupled to turn Ca2+
oscillations into membrane potential ﬂuctuations in early
stage of differentiation.32
Nifedipine, a blocker of L-type Ca2+ channels, also
reduced amplitude of Ca2+ transients in electrically stimu-
lated cardiomyocytes.29 It was suggested that the L-type Ca2+
channel is the predominant contributor to spontaneous Ca2+
transients in early differentiation and then Ca2+-induced Ca2+
release takes over the role of major contributor to Ca2+ trans-
ients in late stage differentiation.41 Frequency and amplitude
of Ca2+ transients were both signiﬁcantly increased from early
to late stage differentiation.38
As the exposure of mouse ESC-CMs to caffeine elicited a
bigger size of Ca2+ transients during differentiation, the effects
of differentiation on SR were proposed to be increasing its
volume and Ca2+ content.38
As for the Ca2+-removal mechanism, NCX  was suggested
to be the main contributor in the early stage of differentiation
whereas sarcoplasmic reticulum Ca2+-ATPase (SERCA) takes
over the main role in the late stage of differentiation.41 In a
later study,42 however, SERCA was evaluated to be responsible
for ∼76% of total Ca2+ removal, while NCX was responsible for
only ∼21% at early differentiation stage of mouse ESC-CMs.
At late differentiation stage, the contribution of SERCA to Ca2+
removal was further increased to ∼88% while that of NCX was
decreased to ∼10%, indicating that the trend of chronological
changes in contribution of two Ca2+ removal mechanisms is
the same between these two  studies.
3.3.  Ca2+ handling  in  human  ESC-CMs
In a study of human ESC-CMs, ryanodine, thapsigargin, and
caffeine did not affect Ca2+ transients and contraction indi-
cating that SR Ca2+ release does not signiﬁcantly contribute
to Ca2+ handling in early stage of differentiation.43 Instead,
trans-sarcolemmal Ca2+ inﬂux was suggested to contribute
predominantly to Ca2+ handling in human ESC-CMs based
on the ﬁnding that verapamil, a blocker of L-type Ca2+ chan-
nel, completely blocked contraction. Later studies, however,
revealed that there are caffeine-responsive human ESC-CMs
8  Integr Med Res ( 2 0 1 6 ) 3–10
Fig. 2 – Schematic model of Ca2+ handling and AP generation in early stage ESC-CMs and mature cardiomyocytes. In early
stage ESC-CMs, T-tubules are not developed and RyRs are poorly coupled to VDCC. Instead, IP3R is well coupled to NCX and
the IP3R-mediated Ca2+ release predominantly drives spontaneous Ca2+ oscillations which subsequently cause
spontaneous beating even under high extracellular K+ condition.31 Trans-sarcolemmal pathways such as TRPC3 and VDCC
also signiﬁcantly contribute to IP3R-mediated Ca2+ release. Ca2+ removal depends on both NCX and SERCA in the SR. NCX is
believed to translate the spontaneous Ca2+ oscillations into membrane potential ﬂuctuations.32 If the ﬂuctuation of
membrane depolarization reaches a threshold for VDCC, an AP is generated. Ca2+ oscillation is essential for maturation of
T-tubule and RyR-VDCC coupling.34 Therefore, the RyR-mediated Ca2+ release is dominant in mature cardiomyocytes.
AP, action potential; ESC-CMs, embryonic stem cell-derived cardiomyocytes; IP3, inositol-1,4,5-trisphosphate; IP3R,
inositol-1,4,5-trisphosphate receptor; NCX, Na+/Ca2+ exchanger; RyRs, ryanodine receptor channels; SERCA, sarcoplasmic
reticulum Ca2+-ATPase; SR, sarcoplasmic reticulum; T-tubule, transverse tubule; VDCC, voltage-dependent L-type Ca2+channel.
as well as caffeine-insensitive human ESC-CMs.44,45 Further-
more,  the presence of SR Ca2+ release channels such as RyR2
and IP3R was also demonstrated by immunostaining studies.45
Ca2+ sparks were also identiﬁed by confocal Ca2+ imaging.45–47
The involvement of IP3-dependent Ca2+ release in intracel-
lular Ca2+ transient was demonstrated in human ESC-CMs
by using angiotensin II (AT-II) and endothelin 1 (ET-1), which
activate the IP3R-mediated Ca2+ release.48 As Ca2+ exclusion
pathways, SERCA2 and NCX were expressed at levels com-
parable to those of the adult porcine myocardium. However,
other Ca2+-regulatory proteins such as calsequestrin, triadin,
junction, and phospholamban were not detectable in humanESC-CMs.43,44 The absence of calsequestrin and phospholam-
ban is possibly the cause for the dysfunctional SR seen in
Ca2+-handling of human ESC-CMs. Indeed, a somatic gene-
transfer of calsequestrin into human ESC-CMs rendered their
Ca2+ handling more  adult-like, as demonstrated by augmented
size of Ca2+-transient and accelerated kinetics.494.  Conclusion  and  future  directions
Electrophysiological properties and Ca2+ handling features
are signiﬁcantly different between early stage ESC-CMs and
Jm
t
r
r
C
p
o
C
d
s
i
m
C
N
A
T
P
K
2
r.B. Youm/Automaticity and calcium handling of ESC-CMs 
ature cardiomyocytes. The most prominent difference lies in
he Ca2+ recruitment mechanism. Immature cardiomyocytes
ely on trans-sarcolemmal Ca2+ inﬂux and IP3R-mediated Ca2+
elease while mature cardiomyocytes rely on RyR-mediated
a2+ release with well-developed T-tubular system and cou-
ling between RyR and L-type Ca2+ channels. However, the role
f TRPC3 in spontaneous Ca2+ oscillation in early stage ESC-
Ms  is not fully resolved. Studies on the role of IKCa in diastolic
epolarization of pacemaker potential is also in very primitive
tage. It is essential to integrate all the aspects of electrophys-
ology and Ca2+ handling into a comprehensive mathematical
odel.
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